Resistant Hypertension: Diagnosis and Real-World Challenges
Summary by hcplive.com
3 Articles
3 Articles
All
Left
Center
Right
Lorundrostat shows promise for uncontrolled, treatment-resistant hypertension
By Lucy Piper, medwireNews ReportermedwireNews: Lorundrostat, a selective aldosterone synthase inhibitor, shows blood pressure-lowering potential in people with uncontrolled and treatment-resistant hypertension, according to the Advance-HTN trial.This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.Read the full story on the L’Institut Servier websiteImage credit: © Kurhan / stock.adobe.com …
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage